Product Reports Resources Pricing Login Book a demo

MacroGenics

Biotech & Life Sciences · Rockville, United States · Founded 2000 · IPO 2013

Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases

Valuation $117M
Revenue $164M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Knowledge graph
News Bora buys MacroGenics' Maryland biologics plant for $122.5M as Cloudforce adds 250 jobs Aug 13, 2026 News Gilead exercises option, triggering $10M payment to MacroGenics Aug 11, 2026

Talent graph

MacroGenics's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

13 investors on MacroGenics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage
Alexandria Equities
InterWest Partners
Startech Early Ventures
OrbiMed
MPM BioImpact
Series B+ 8 investors entered at this stage
Rockefeller University
Institute for Systems Biology
Mithra Ventures
TPG
Ventures West
Alta Partners
Red Abbey Venture Partners
ETP Ventures

MacroGenics mafia

Startups founded by MacroGenics alumni

Former MacroGenics employees who went on to start their own companies. Sorted by Dealroom signal score.

NextCureEst. 2015
MRMichael RichmanUnited States
Signal score67
Artomatix CloudEst. 2014
Eric RisserIreland
Signal score59
Integrated DiagnosticsEst. 2005
Leroy HoodUnited States
Signal score57
XGraphEst. 2008
Paul MooreUnited States
Signal score57
VirobayEst. 2006
Heather PrestonUnited States
Signal score54

Book a demo to explore the full alumni network →

Global footprint

Where MacroGenics has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States99.6%
🇦🇷 Argentina0.4%
2 countries shown
Web traffic by country
8.6K monthly visits
across markets
🇺🇸 United States70.9%
🇮🇳 India15.1%
🇯🇵 Japan7%
🇬🇧 United Kingdom4.7%
🇨🇦 Canada2.3%
Top 5 markets shown

Patent intelligence

$134M patent portfolio · 69 active families

Estimated portfolio value
$134M
114.9% of market cap · 3.6× smaller than top peer Genmab ($488M)
69 active patent families
Where MacroGenics innovates Antiendomysial antibodiesAntigenBiochemistryCancer researchCarcinosis

Where MacroGenics concentrates vs peers

Each axis is a top-10 topic across MacroGenics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about MacroGenics

An AI-synthesized read of the highest-engagement posts about MacroGenics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MacroGenics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles